This is where AI in medicine gets genuinely consequential. Researchers at MIT and Massachusetts General Hospital developed Mirai, an AI system that analyzes mammograms and estimates a woman’s breast cancer risk up to five years into the future. Important distinction: it is not literally seeing a cancer five years before it exists. It is detecting subtle patterns associated with elevated future risk. That matters. Instead of treating every screening schedule largely the same, systems like Mirai could eventually help identify who needs closer surveillance, supplemental imaging or earlier intervention. The bigger shift is not simply better cancer detection. It is medicine moving from reacting to disease toward anticipating it. HEADLINE AI CAN PREDICT BREAST CANCER RISK 5 YEARS EARLY SUBHEADLINE MIT and Mass General’s Mirai AI analyzes mammograms to identify women at elevated risk of developing breast cancer years before diagnosis, pointing toward a future of far more personalize...